A deep learning-enabled toolkit for the 3D segmentation of ventricular cardiomyocytes
Clinical Snapshot
PICO Framework
| P — Population | Ventricular cardiomyocytes from seven species (including mouse, rat, rabbit, pig, human, and elephant) imaged via 3D confocal microscopy, encompassing healthy tissue, post-myocardial infarction samples, and ex vivo slice cultures |
| I — Intervention | A deep learning-enabled toolkit for automated and semi-automated 3D segmentation of individual cardiomyocytes in confocal microscopy volumes, incorporating an image restoration workflow to address spatially varying blur and other imaging artefacts |
| C — Comparator | Conventional 2D segmentation approaches used to infer 3D cardiomyocyte morphology; expert manual annotation as ground truth reference standard |
| O — Outcomes | Primary: segmentation accuracy measured by adapted Rand error on a held-out test set; Secondary: semi-automatic workflow throughput (cells per minute), cross-species and cross-condition generalisability, and open-source accessibility of toolkit and annotated dataset |
Bottom Line
This methodological paper presents a rigorously developed, open-source deep learning toolkit for 3D segmentation of individual ventricular cardiomyocytes from confocal microscopy volumes. The toolkit achieves approximately 94% voxel-pair agreement with expert annotation (adapted Rand error 0.063 ± 0.034) and a semi-automatic throughput of 3 cells per minute on challenging unseen data. Critically, validation spans seven species — including human — and multiple experimental conditions including post-myocardial infarction tissue, substantially strengthening generalisability claims. The open-source design with a graphical user interface democratises access for non-computational laboratories. Key limitations include the absence of formal inter-annotator reliability data for the reference standard, incomplete reporting of test set composition, and no independent validation of downstream morphometric parameter accuracy. The stated DOI also raises a metadata integrity concern warranting verification. For Australian cardiac researchers, this toolkit represents a meaningful advance over 2D inference methods and is immediately applicable to preclinical and translational studies of cardiac microstructure. It does not require TGA approval or PBS consideration. Senior clinicians and researchers should regard this as a high-quality research tool with strong preliminary validation, while awaiting independent external replication of performance claims.
Key Findings
P Value: Not applicable — performance benchmarking study; no hypothesis testing reported
Effect Size: Adapted Rand error of 0.063 ± 0.034, corresponding to approximately 94% voxel-pair agreement between automated segmentation and expert annotation
Primary Outcome: Automatic 3D cardiomyocyte segmentation accuracy on held-out test set, measured by adapted Rand error
Nnt Or Sensitivity: Semi-automatic workflow throughput: 3 cells per minute on a challenging, previously unseen dataset; no sensitivity/specificity metrics reported in the abstract
Confidence Interval: Not formally reported; variability expressed as standard deviation (±0.034)
Clinical Application
Open-source availability with a dedicated graphical user interface makes the toolkit accessible to laboratories without dedicated computational expertise. Semi-automatic throughput of 3 cells per minute is operationally feasible for research-scale analyses. Deep learning inference requires GPU-capable hardware, which is increasingly standard in research institutions but may require infrastructure investment in smaller laboratories. This toolkit has direct relevance to Australian cardiac research institutions, including those affiliated with the National Heart Foundation of Australia and university-based cardiac physiology groups. It is not a clinical diagnostic tool and therefore does not require TGA approval or PBS listing. It is relevant to NHMRC-funded preclinical cardiac research and may support Australian contributions to international cardiac cell modelling consortia. The inclusion of human cardiac tissue data is particularly relevant to Australian biobanking and cardiac surgical research programs. RACGP guidelines are not directly applicable, as this is a research tool rather than a clinical intervention. Preclinical and translational cardiac researchers working with ventricular myocardial tissue from any of the seven validated species; particularly relevant to groups studying cardiac remodelling in myocardial infarction, heart failure, and cardiomyopathies
Abstract
Segmentation of cardiomyocytes in microscopic 3D volumes is key to our understanding of cardiac (patho-)physiology; however, it poses substantial experimental and analytical challenges. Therefore, researchers often resort to inferring 3D information from 2D segmentations, which can lead to biased and incorrect conclusions. Deep learning-based methods are showing promise with respect to robustly segmenting objects in volumes acquired using various imaging modalities; yet, they have not been applied to high-resolution 3D cardiomyocyte segmentations, and suitable open-source tools and datasets are lacking. Here, we present a deep learning-enabled toolkit for segmentation of individual cardiomyocytes in 3D confocal microscopy volumes. We include a dataset of 73 volumes with expert annotations, covering seven species, including mouse, human, and elephant, and containing samples generated under different experimental conditions, such as post-myocardial infarction and ex vivo slice cultures. The toolkit additionally contains an image restoration workflow to address imaging-related artefacts, such as spatially varying blur. Our automatic cardiomyocyte segmentation workflow achieved an adapted Rand error of 0.063 ± 0.034 (∼94% voxel-pair agreement) on the test set. Our semi-automatic workflow reached a throughput of 3 cells min-1 on a challenging, previously unseen dataset. The toolkit and data are open-source and accessible through a dedicated graphical user interface. In summary, we provide an accessible toolkit enabling researchers to extract quantitative data on cardiomyocyte microstructure from 3D confocal image stacks of cardiac tissue. Given the size and diversity of our dataset, we expect our methods to perform well across species and experimental conditions, facilitating high-quality 3D reconstructions of large numbers of individual cardiomyocytes. KEY POINTS: 3D cardiomyocyte microstructure is a key determinant of cardiac function in health and disease. However, reliable extraction and quantification of 3D cardiomyocyte cytoarchitecture pose significant experimental and computational challenges. We present an effective experimental protocol and a deep learning-enabled toolkit for sample preparation and 3D analysis of cardiomyocyte morphology in ventricular myocardium. Our method is validated across seven species (mouse to human) and in samples prepared in diverse experimental conditions from a range of models, including myocardial infarction and ex vivo tissue culture, highlighting the robustness and versatility of our workflow. Our open-source dataset and toolkit enable large-scale analyses and extraction of realistic 3D geometries of ventricular microstructure. These can be used to explore a host of research questions and provide a new resource for modelling cardiac function at the cellular level.
References
- 1.Greiner, J., Frangiamore, F., Sonak, F., Madl, J., Seidel, T., Kohl, P., & Rog-Zielinska, E. A. (2026). A deep learning-enabled toolkit for the 3D segmentation of ventricular cardiomyocytes. The Journal of Physiology. https://doi.org/10.48550/arXiv.1804.03999
Related Research
Bioelectrochemistry (Amsterdam, Netherlands)
From data to diagnosis: A comprehensive review of machine learning-driven wearable sensors in healthcare.
2 Aug 2026
Ultrasound in medicine & biology
A Systematic Review: The Application of Attention Mechanisms in Medical Ultrasound Image Processing
2 Aug 2026
Journal of the American Medical Informatics Association : JAMIA
Explainable machine learning in healthcare: methods, interpretation, and applications for clinical research
2 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service